Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Curr Res Microb Sci ; 3: 100155, 2022.
Article in English | MEDLINE | ID: mdl-35909616

ABSTRACT

Avian infectious bronchitis virus (IBV) causes highly contagious respiratory reproductive and renal system diseases in chickens, and emergence of serotypic variants resulting from mutations in the viral S gene hampers vaccine management for IBV infection. In this study, to facilitate the molecular analysis of IBV pathogenesis and the development of a new-generation IBV vaccine, we established a reverse genetics system (RGS) for cloning the full-length cDNA of the IBV C-78E128 attenuated strain in a bacterial artificial chromosome (BAC). The BAC-cloned C-78E128 cDNA generated infectious viruses with biological properties of the parental C-78E128 strain with regard to an avirulent phenotype, tissue tropism and induction of virus neutralizing (VN) antibody in vivo. To assess the feasibility of genetic manipulation of the IBV genome using the BAC-based RGS, the S gene of the BAC-cloned C-78E128 cDNA was replaced with that of the IBV S95E4 virulent strain, which differs from the C-78E128 strain in serotype and tissue tropism, by bacteriophage lambda Red-mediated homologous recombination in Escherichia coli (E. coli). The resultant S gene recombinant virus was found to be avirulent and fully competent to induce a serotype-specific VN antibody against the S95 strain; however, the S gene recombinant virus did not fully recapitulate the tissue tropism of the S95E4 strain. These data imply that serotype-specific VN immunogenicity, but not tissue-tropism and pathogenicity, of IBV is determined by the viral S gene. The IBV BAC-based RGS that enables cloning and manipulation of the IBV virus genome entirely in E. coli provides a useful platform for the molecular analyses of IBV pathogenesis and the development of rationally designed IBV recombinant vaccines.

2.
J Virol Methods ; 299: 114303, 2022 01.
Article in English | MEDLINE | ID: mdl-34606795

ABSTRACT

INTRODUCTION: Plaque assay (PA) is a gold standard for virus titration and neutralization of various cytopathic viruses, including avian nephritis virus (ANV), the etiological agent associated with kidney disorders in chickens. In this study, as an alternative to the labor-intensive PA, we developed a spectrophotometric microplate assay (MA) for ANV titration and neutralization based on the virus cytopathicity to primary chicken kidney (CK) cells. METHODS: CK cells were infected with ANV in the presence or absence of chicken serum in a 96-well microplate, and the virus-induced cytolysis was quantified by measurement of neutral red uptake using a spectrophotometer. The absorbance values obtained were subjected to a sigmoidal four-parameter logistic regression analysis for the virus titer determination and serum neutralization assessment. Accuracy and reliability of the serum neutralization MA in comparison to the standard PA was statistically evaluated. RESULTS: The ANV-MA was capable of quantifying infectious virus titers based on a virus dose-dependent cytolysis of CK cells, and serum neutralization could be assessed as an inhibition of the virus-induced cytolysis accordingly. Statistical evaluation using a 2 × 2 contingency table and receiver-operating characteristic analyses showed 82 % sensitivity, 99 % specificity and 0.97 area under the curve, supporting an overall diagnostic accuracy of the neutralization MA. CONCLUSION: The newly developed MA using simplified experimental procedures in the microplate format and direct spectophotometric data readout is readily applicable to general laboratories for high-throughput screening of serum neutralization of ANV.


Subject(s)
Avastrovirus , Animals , Antibodies, Viral , Chickens , Neutralization Tests/methods , Reproducibility of Results
3.
Vaccine ; 33(39): 5204-11, 2015 Sep 22.
Article in English | MEDLINE | ID: mdl-26254309

ABSTRACT

Enterotoxigenic Escherichia coli (ETEC) causes severe diarrhea in both neonatal and weaned pigs. Because the cholera toxin B subunit (CTB) has a high level of amino acid identity to the ETEC heat-labile toxin (LT) B-subunit (LTB), we selected MucoRice-CTB as a vaccine candidate against ETEC-induced pig diarrhea. When pregnant sows were orally immunized with MucoRice-CTB, increased amounts of antigen-specific IgG and IgA were produced in their sera. CTB-specific IgG was secreted in the colostrum and transferred passively to the sera of suckling piglets. IgA antibodies in the colostrum and milk remained high with a booster dose after farrowing. Additionally, when weaned minipigs were orally immunized with MucoRice-CTB, production of CTB-specific intestinal SIgA, as well as systemic IgG and IgA, was induced. To evaluate the cross-protective effect of MucoRice-CTB against ETEC diarrhea, intestinal loop assay with ETEC was conducted. The fluid volume accumulated in the loops of minipigs immunized with MucoRice-CTB was significantly lower than that in control minipigs, indicating that MucoRice-CTB-induced cross-reactive immunity could protect weaned pigs from diarrhea caused by ETEC. MucoRice-CTB could be a candidate oral vaccine for inducing both passive and active immunity to protect both suckling and weaned piglets from ETEC diarrhea.


Subject(s)
Diarrhea/veterinary , Enterotoxigenic Escherichia coli/immunology , Escherichia coli Infections/veterinary , Escherichia coli Vaccines/immunology , Immunity, Mucosal , Oryza/genetics , Swine Diseases/prevention & control , Administration, Oral , Animals , Antibodies, Bacterial/blood , Colostrum/immunology , Diarrhea/prevention & control , Enterotoxigenic Escherichia coli/genetics , Escherichia coli Infections/prevention & control , Escherichia coli Vaccines/administration & dosage , Escherichia coli Vaccines/genetics , Female , Immunization, Passive , Immunoglobulin A/blood , Immunoglobulin G/blood , Milk/immunology , Pregnancy , Serum/immunology , Swine , Vaccination , Vaccines, Edible/administration & dosage , Vaccines, Edible/genetics , Vaccines, Edible/immunology
4.
Retrovirology ; 10: 135, 2013 Nov 14.
Article in English | MEDLINE | ID: mdl-24229420

ABSTRACT

BACKGROUND: HIV-1 Nef is a viral accessory protein critical for AIDS progression. Nef lacks intrinsic catalytic activity and binds multiple host cell signaling proteins, including Hck and other Src-family tyrosine kinases. Nef binding induces constitutive Hck activation that may contribute to HIV pathogenesis by promoting viral infectivity, replication and downregulation of cell-surface MHC-I molecules. In this study, we developed a yeast-based phenotypic screen to identify small molecules that inhibit the Nef-Hck complex. RESULTS: Nef-Hck interaction was faithfully reconstituted in yeast cells, resulting in kinase activation and growth arrest. Yeast cells expressing the Nef-Hck complex were used to screen a library of small heterocyclic compounds for their ability to rescue growth inhibition. The screen identified a dihydrobenzo-1,4-dioxin-substituted analog of 2-quinoxalinyl-3-aminobenzene-sulfonamide (DQBS) as a potent inhibitor of Nef-dependent HIV-1 replication and MHC-I downregulation in T-cells. Docking studies predicted direct binding of DQBS to Nef which was confirmed in differential scanning fluorimetry assays with recombinant purified Nef protein. DQBS also potently inhibited the replication of HIV-1 NL4-3 chimeras expressing Nef alleles representative of all M-group HIV-1 clades. CONCLUSIONS: Our findings demonstrate the utility of a yeast-based growth reversion assay for the identification of small molecule Nef antagonists. Inhibitors of Nef function discovered with this assay, such as DQBS, may complement the activity of current antiretroviral therapies by enabling immune recognition of HIV-infected cells through the rescue of cell surface MHC-I.


Subject(s)
Anti-HIV Agents/pharmacology , Drug Evaluation, Preclinical/methods , Proto-Oncogene Proteins c-hck/antagonists & inhibitors , Quinoxalines/pharmacology , Saccharomyces cerevisiae/drug effects , Sulfonamides/pharmacology , nef Gene Products, Human Immunodeficiency Virus/antagonists & inhibitors , Anti-HIV Agents/isolation & purification , Humans , Molecular Docking Simulation , Protein Binding/drug effects , Proto-Oncogene Proteins c-hck/genetics , Quinoxalines/isolation & purification , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Sulfonamides/isolation & purification , nef Gene Products, Human Immunodeficiency Virus/genetics , Benzenesulfonamides
5.
Virus Genes ; 43(1): 72-8, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21559974

ABSTRACT

Previously, we have reported that a serial passage of 83P-5 strain of porcine epidemic diarrhea virus (PEDV) in Vero cells resulted in a growth adaptation of the virus in cultured cells at the 22nd passage. In this study, we further maintained the 83P-5 in Vero cells up to the 100th passage and analyzed changes in the spike (S), membrane (M), and nucleocapsid (N) gene sequences and pathogenicity of the virus at the 34th, 61st, and 100th passage levels. Sequence analyses revealed a strong selection for the S gene of 83P-5 in Vero cells, and virtually all mutations occurring at the 34th and 61st passages had been carried over to the 100th-passaged virus. In contrast, the viral M and N genes showed a strong conservation during the serial passage. Pigs experimentally infected with the 34th- or 61st-passaged virus, but not the 100th-passaged virus, exhibited diarrhea, indicating an attenuation of the 83P-5 at the 100th passage. Interestingly, S protein of the attenuated 100th-passaged 83P-5 showed a remarkable sequence similarity to that of previously reported DR-13 strain of attenuated PEDV that also had been established by serial passage in Vero cells. Further studies will be required to define whether the mutations in the S gene of 83P-5 that had been selected and accumulated during the serial passages are indeed the causalities of the growth adaptation in vitro and the attenuation of virulence in vivo.


Subject(s)
Adaptation, Biological , Membrane Glycoproteins/genetics , Mutation, Missense , Porcine epidemic diarrhea virus/growth & development , Porcine epidemic diarrhea virus/genetics , Viral Envelope Proteins/genetics , Animals , Chlorocebus aethiops , Coronavirus M Proteins , Coronavirus Nucleocapsid Proteins , DNA Mutational Analysis , Molecular Sequence Data , Nucleocapsid Proteins , Porcine epidemic diarrhea virus/pathogenicity , RNA, Viral/genetics , Sequence Analysis, DNA , Serial Passage , Spike Glycoprotein, Coronavirus , Vero Cells , Viral Matrix Proteins/genetics , Virulence
6.
J Vet Med Sci ; 73(6): 837-40, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21289471

ABSTRACT

A 5-month-old female Citron-crested Cockatoo (Cacatua sulphurea citrinocristata) that was born and hand-reared in Japan died with suspected proventricular dilatation disease (PDD). Macroscopic and microscopic examinations of the bird revealed characteristic features of PDD, i.e., distention of the proventriculus and infiltration of lymphocytes and plasma cells in ganglia of various organs and in central and peripheral nerves. A linkage of this PDD case to infection with avian bornavirus (ABV) was documented by RT-PCR amplification of the virus genomes from the affected bird. Phylogenetic analysis revealed that the ABV identified in this study clustered into the genotype 2, which is one of the dominant ABV genotypes worldwide. To the best of our knowledge, this is the first report of a natural case of PDD associated with ABV infection in Japan.


Subject(s)
Bird Diseases/pathology , Bird Diseases/virology , Bornaviridae/isolation & purification , Cockatoos , Dilatation, Pathologic/veterinary , Mononegavirales Infections/veterinary , Proventriculus/pathology , Amino Acid Sequence , Animals , Base Sequence , Bornaviridae/genetics , Dilatation, Pathologic/pathology , Dilatation, Pathologic/virology , Fatal Outcome , Female , Histocytochemistry/veterinary , Japan , Molecular Sequence Data , Mononegavirales Infections/pathology , Mononegavirales Infections/virology , Phylogeny , Proventriculus/virology , RNA, Bacterial/chemistry , RNA, Bacterial/genetics , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sequence Alignment
7.
Vet Microbiol ; 147(3-4): 283-91, 2011 Jan 27.
Article in English | MEDLINE | ID: mdl-20673616

ABSTRACT

H5 and H7 highly pathogenic avian influenza virus (HPAIV) represent a major global concern in poultries and human health. Avian influenza (AI) vaccines are available but not preferred for field applications, primarily because vaccination interferes with sero-surveillances of AIV infection. To overcome the problem, ELISA systems using non-structural protein 1 (NS1) of AIV as antigens (NS1-ELISA) have been developed to measure anti-NS1 antibodies that are raised in AIV-infected but not in vaccinated chickens. However, some AI-vaccinated chickens having a weak anti-virus immune response may subsequently be infected with AIV and spread the virus. This raises a concern for the validity of NS1-ELISA to detect AIV infection in previously vaccinated chickens. In this study, we developed NS1-ELISA and assessed its feasibility to detect HPAIV infection in chickens previously immunized with H5 or H7 AI vaccines. The results indicated that the NS1-ELISA could identify HPAIV infection in both unvaccinated and vaccinated chickens at 1 week after infection in correlation with results from time-consuming virus isolation tests. Taken together, the NS1-ELISA system would be valuable tool to define HPAIV infection when AI vaccine program is in place.


Subject(s)
Antibodies, Viral/blood , Influenza Vaccines/immunology , Influenza in Birds/diagnosis , Influenza in Birds/immunology , Poultry Diseases/diagnosis , Poultry Diseases/immunology , Viral Nonstructural Proteins/immunology , Animals , Chickens , Enzyme-Linked Immunosorbent Assay/veterinary , Influenza A virus/immunology , Influenza in Birds/virology , Poultry Diseases/virology
8.
ACS Chem Biol ; 4(11): 939-47, 2009 Nov 20.
Article in English | MEDLINE | ID: mdl-19807124

ABSTRACT

Nef is an HIV-1 accessory protein essential for AIDS progression and an attractive target for drug discovery. Lack of a catalytic function makes Nef difficult to assay in chemical library screens. We developed a high-throughput screening assay for inhibitors of Nef function by coupling it to one of its host cell binding partners, the Src-family kinase Hck. Hck activation is dependent upon Nef in this assay, providing a direct readout of Nef activity in vitro. Using this screen, a unique diphenylfuropyrimidine was identified as a strong inhibitor of Nef-dependent Hck activation. This compound also exhibited remarkable antiretroviral effects, blocking Nef-dependent HIV replication in cell culture. Structurally related analogs were synthesized and shown to exhibit similar Nef-dependent antiviral activity, identifying the diphenylfuropyrimidine substructure as a new lead for antiretroviral drug development. This study demonstrates that coupling noncatalytic HIV accessory factors with host cell target proteins addressable by high-throughput assays may afford new avenues for the discovery of anti-HIV agents.


Subject(s)
Anti-HIV Agents/chemistry , Anti-HIV Agents/pharmacology , HIV-1/drug effects , Proto-Oncogene Proteins c-hck/metabolism , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology , nef Gene Products, Human Immunodeficiency Virus/metabolism , Cell Line , Drug Evaluation, Preclinical , Enzyme Activation , HIV-1/physiology , High-Throughput Screening Assays , Humans , Molecular Structure , Protein Binding , Structure-Activity Relationship , Virus Replication
9.
J Virol ; 82(1): 321-34, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17942538

ABSTRACT

Molecular differences in the envelope glycoproteins of human immunodeficiency virus type 1 and simian immunodeficiency virus (SIV) determine virus infectivity and cellular tropism. To examine how these properties contribute to productive infection in vivo, rhesus macaques were inoculated with strains of single-cycle SIV (scSIV) engineered to express three different envelope glycoproteins with full-length (TM(open)) or truncated (TM(stop)) cytoplasmic tails. The 239 envelope uses CCR5 for infection of memory CD4(+) T cells, the 316 envelope also uses CCR5 but has enhanced infectivity for primary macrophages, and the 155T3 envelope uses CXCR4 for infection of both naive and memory CD4(+) T cells. Separate groups of six rhesus macaques were inoculated intravenously with mixtures of TM(open) and TM(stop) scSIV(mac)239, scSIV(mac)316, and scSIV(mac)155T3. A multiplex real-time PCR assay specific for unique sequence tags engineered into each virus was then used to measure viral loads for each strain independently. Viral loads in plasma peaked on day 4 for each strain and were resolved below the threshold of detection within 4 to 10 weeks. Truncation of the envelope cytoplasmic tail significantly increased the peak of viremia for all three envelope variants and the titer of SIV-specific antibody responses. Although peak viremias were similar for both R5- and X4-tropic viruses, clearance of scSIV(mac)155T3 TM(stop) was significantly delayed relative to the other strains, possibly reflecting the infection of a CXCR4(+) cell population that is less susceptible to the cytopathic effects of virus infection. These studies reveal differences in the peaks and durations of a single round of productive infection that reflect envelope-specific differences in infectivity, chemokine receptor specificity, and cellular tropism.


Subject(s)
Antibodies, Viral/blood , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/growth & development , Simian Immunodeficiency Virus/immunology , Viral Envelope Proteins/genetics , Viremia , Animals , Macaca mulatta , Reverse Transcriptase Polymerase Chain Reaction/methods , Simian Immunodeficiency Virus/genetics , Viral Load
10.
J Virol ; 81(22): 12210-7, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17804491

ABSTRACT

The TRIM5 family of proteins contains a RING domain, one or two B boxes, and a coiled-coil domain. The TRIM5alpha isoform also encodes a C-terminal B30.2(SPRY) domain, differences within which define the breadth and potency of TRIM5alpha-mediated retroviral restriction. Because Macaca nemestrina animals are susceptible to some human immunodeficiency virus (HIV) isolates, we sought to determine if differences exist in the TRIM5 gene and transcripts of these animals. We identified a two-nucleotide deletion (Delta2) in the transcript at the 5' terminus of exon 7 in all M. nemestrina TRIM5 cDNA clones examined. This frameshift results in a truncated protein of 300 amino acids lacking the B30.2(SPRY) domain, which we have named TRIM5theta. This deletion is likely due to a single nucleotide polymorphism that alters the 3' splice site between intron 6 and exon 7. In some clones, a deletion of the entire 27-nucleotide exon 7 (Deltaexon7) resulted in the restoration of the TRIM5 open reading frame and the generation of another novel isoform, TRIM5eta. There are 18 amino acid differences between M. nemestrina TRIM5eta and Macaca mulatta TRIM5alpha, some of which are at or near locations previously shown to affect the breadth and potency of TRIM5alpha-mediated restriction. Infectivity assays performed on permissive CrFK cells stably transduced with TRIM5eta or TRIM5theta show that these isoforms are incapable of restricting either HIV type 1 (HIV-1) or simian immunodeficiency virus infection. The expression of TRIM5 alleles incapable of restricting HIV-1 infection may contribute to the previously reported increased susceptibility of M. nemestrina to HIV-1 infection in vivo.


Subject(s)
Carrier Proteins/genetics , HIV Infections/veterinary , HIV-1 , Macaca nemestrina/immunology , Monkey Diseases/genetics , Alleles , Amino Acid Sequence , Animals , Carrier Proteins/analysis , Carrier Proteins/metabolism , HIV Infections/genetics , HIV Infections/immunology , Humans , Macaca nemestrina/genetics , Macaca nemestrina/virology , Molecular Sequence Data , Monkey Diseases/immunology , Monkey Diseases/virology , Polymorphism, Genetic , Protein Isoforms/analysis , Protein Isoforms/genetics , Protein Isoforms/metabolism , Transcription, Genetic
11.
J Exp Med ; 200(10): 1299-314, 2004 Nov 15.
Article in English | MEDLINE | ID: mdl-15545355

ABSTRACT

The mechanisms linking human immunodeficiency virus replication to the progressive immunodeficiency of acquired immune deficiency syndrome are controversial, particularly the relative contribution of CD4+ T cell destruction. Here, we used the simian immunodeficiency virus (SIV) model to investigate the relationship between systemic CD4+ T cell dynamics and rapid disease progression. Of 18 rhesus macaques (RMs) infected with CCR5-tropic SIVmac239 (n=14) or CXCR4-tropic SIVmac155T3 (n=4), 4 of the former group manifested end-stage SIV disease by 200 d after infection. In SIVmac155T3 infections, naive CD4+ T cells were dramatically depleted, but this population was spared by SIVmac239, even in rapid progressors. In contrast, all SIVmac239-infected RMs demonstrated substantial systemic depletion of CD4+ memory T cells by day 28 after infection. Surprisingly, the extent of CD4+ memory T cell depletion was not, by itself, a strong predictor of rapid progression. However, in all RMs destined for stable infection, this depletion was countered by a striking increase in production of short-lived CD4+ memory T cells, many of which rapidly migrated to tissue. In all rapid progressors (P <0.0001), production of these cells initiated but failed by day 42 of infection, and tissue delivery of new CD4+ memory T cells ceased. Thus, although profound depletion of tissue CD4+ memory T cells appeared to be a prerequisite for early pathogenesis, it was the inability to respond to this depletion with sustained production of tissue-homing CD4+ memory T cells that best distinguished rapid progressors, suggesting that mechanisms of the CD4+ memory T cell generation play a crucial role in maintaining immune homeostasis in stable SIV infection.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Immunologic Memory , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/physiopathology , Simian Immunodeficiency Virus/pathogenicity , Analysis of Variance , Animals , Bromodeoxyuridine , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/metabolism , Disease Progression , Flow Cytometry , Fluorescent Antibody Technique , Macaca mulatta , Male , Species Specificity
12.
Nahrung ; 47(5): 354-8, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14609094

ABSTRACT

Angiotensin I-converting enzyme (ACE) inhibitory peptide was isolated from wheat gliadin hydrolysate prepared with acid protease. Consecutive purification methods were used for peptide isolation including ion-exchange chromatography, size-exclusion chromatography, and reverse-phase high-performance liquid chromatography. The amino acid sequence of this peptide was identified as Ile-Ala-Pro, and the ACE inhibitory activity (IC50 value) was 2.7 microM. The hypotensive activity of Ile-Ala-Pro on spontaneously hypertensive rats was investigated. This peptide inhibited the hypertensive activity of angiotensin I with intravenous injection, and decreased the blood pressure significantly with intraperitoneal administration.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/isolation & purification , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Gliadin/chemistry , Protein Hydrolysates/chemistry , Amino Acid Sequence , Angiotensin-Converting Enzyme Inhibitors/chemistry , Animals , Antihypertensive Agents/chemistry , Antihypertensive Agents/isolation & purification , Antihypertensive Agents/pharmacology , Chromatography, Gel , Chromatography, High Pressure Liquid/methods , Chromatography, Ion Exchange/methods , Inhibitory Concentration 50 , Male , Peptidyl-Dipeptidase A/metabolism , Rats , Rats, Inbred SHR , Triticum/chemistry
13.
J Nutr ; 133(6): 1887-91, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12771334

ABSTRACT

Epsilon-polylysine (epsilon-PL) has been used as a food additive in Japan for many years. In this study, it inhibited human and porcine pancreatic lipase activity in substrate emulsions containing bile salts and phosphatidylcholine, in the concentration range of 10-1000 mg/L. At the same concentrations, it also destroyed the emulsifying activity, suggesting that lipase inhibitory activity and emulsion breakdown activity were associated. Epsilon-PL inhibited porcine pancreatic lipase activity and destroyed emulsion breakdown activity at 1000 mg/L in the substrate containing bile salts and phosphatidylcholine alone. Epsilon-PL did not inhibit lipase activity or affect emulsifying activity at 1000 mg/L in the substrates containing arabic gum and polyvinyl alcohol. A comparison of lipase inhibitory activity between epsilon-PL and three types of alpha-PL with differing polymerization rates was performed. The lipase inhibitory activity of epsilon-PL was not different from that of alpha-PL (44 lysine residues). Epsilon-PL maintained its inhibitory activity after incubation with trypsin, alpha-chymotrypsin and pepsin, whereas alpha-PL did not. The effect of epsilon-PL on postprandial hypertriacylglyceridemia was investigated in rats. The plasma triacylglycerol concentration in rats intragastrically administered > or =15 mg/kg of both fat emulsion and epsilon-PL was significantly lower at 2 and 3 h after administration than that in rats administered fat emulsion alone (P < 0.05). These results strongly suggest that epsilon-PL is able to suppress dietary fat absorption from the small intestine by inhibiting pancreatic lipase activity.


Subject(s)
Enzyme Inhibitors/pharmacology , Hypertriglyceridemia/prevention & control , Lipase/antagonists & inhibitors , Pancreas/enzymology , Polylysine/pharmacology , Postprandial Period , Animals , Male , Osmolar Concentration , Rats , Rats, Sprague-Dawley , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...